New research (the Ver-A-T1D trial) presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15-19 September) shows that slow-release (SR) verapamil ...
Results of the CLVer clinical trial showed that oral verapamil taken once a day improved the pancreas' insulin secretion by 30% over the first year following diagnosis of T1D when compared with a ...
The old antihypertensive drug verapamil may help reduce insulin requirements and hypoglycemic episodes in adults with type 1 diabetes, new research suggests. Results from the study were published ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Young people with new type 1 diabetes had higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback